Department of Breast Oncology, Aichi Cancer Center Hospital, 1-1 Kanokoden, Chikusa-ku, Nagoya, 464-8681, Japan.
Department of Breast Surgery, Nagoya City University Graduate School of Medicine, 1, Kawasumi, Mizuho-cho, Mizuho-ku, Nagoya, 467-8601, Japan.
BMC Cancer. 2021 May 13;21(1):548. doi: 10.1186/s12885-021-08240-6.
Chemotherapy-induced peripheral neuropathy (CIPN) is a common adverse effect of paclitaxel (PTX). There is no known prophylactic measure, although there are some reports of prevention with compression therapy using surgical gloves. On account of its predominantly subjective symptoms, it is difficult to exclude bias when assessing for CIPN. In this study, we assessed the effectiveness of the same procedure for the prevention of paclitaxel-induced PN based on a double-blind study design.
The patients with early and recurrent breast cancer (with no prior PTX exposure) initiating weekly chemotherapy with PTX 80 mg/m were enrolled. Each patient donned two gloves on each hand at every PTX infusion. Two one-size-smaller gloves were donned on one hand (study side) and two normal-size gloves were donned on the other hand (control side) during 90 min from 30 min before the infusion to 30 min after the end of the infusion. Study side are blind for both patients and assessing physicians according to determination of the study side by research nurses in the chemotherapy unit. The primary outcome was the difference in the frequency of CIPN (motor/sensory) determined by the physician using the common terminology criteria for adverse events (CTCAE v4.0), with an evaluation at each cycle of PTX infusion. McNemar test was used to assess the primary outcome.
Between July 2017 and November 2018, 56 patients were enrolled and 49 patients were evaluated. Overall, Grade ≥ 2 PN (sensory) was observed in 30.6 and 36.7% in the study and control sides, respectively (McNemar p = 0.25). PN (motor) was observed in 4.1 and 6.1% in the study and control sides, respectively (McNemar p = 1.0).
Surgical glove compression therapy showed no statistically significant effect on the incidence of PTX-induced PN.
This study was registered with the University Hospital Medical Information Network (UMIN) Clinical Trials Registry managed by the National University Hospital Council of Japan ( UMIN000027944 ). Registered 26 June 2017.
紫杉醇(PTX)引起的周围神经病变(CIPN)是一种常见的不良反应。目前尚无已知的预防措施,尽管有一些使用手术手套进行压迫治疗预防的报道。由于其主要为主观症状,在评估 CIPN 时很难排除偏倚。在这项研究中,我们根据双盲研究设计评估了相同程序预防紫杉醇引起的 PN 的效果。
入组接受每周紫杉醇 80mg/m 化疗的早期和复发性乳腺癌(无紫杉醇暴露史)患者。每位患者在每次紫杉醇输注时双手各戴两只手套。在输注前 30 分钟至输注结束后 30 分钟的 90 分钟内,一只手戴两只小一码的手套(研究侧),另一只手戴两只正常尺寸的手套(对照侧)。根据化疗病房的研究护士确定的研究侧,患者和评估医生对研究侧均为盲法。主要结局是根据医师使用不良事件通用术语标准(CTCAE v4.0)确定的 CIPN(运动/感觉)频率差异,每个紫杉醇输注周期进行评估。采用 McNemar 检验评估主要结局。
2017 年 7 月至 2018 年 11 月,入组 56 例患者,49 例患者进行了评估。总体而言,研究侧和对照侧分别有 30.6%和 36.7%的患者出现≥2 级 PN(感觉)(McNemar p=0.25)。研究侧和对照侧分别有 4.1%和 6.1%的患者出现 PN(运动)(McNemar p=1.0)。
手术手套压迫治疗对紫杉醇引起的 PN 发生率无统计学显著影响。
本研究在日本国立大学医院理事会管理的大学医院医学信息网络(UMIN)临床试验注册处(UMIN000027944)注册。注册日期为 2017 年 6 月 26 日。